IOL Chemicals And Pharmaceuticals, 524164, IOLCP Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,428.94
18.07
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,318.81
1.21%
1.51

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.68
5.64
4.07

EBITDA CAGR (%)

10 Years
5 Years
3 Years

8.99
-11.17
-17.48

PAT CAGR (%)

10 Years
5 Years
3 Years

45.46
-9.97
-31.97

P:E (Median)

8 Years
5 Years
3 Years

15.08
15.51
15.51

P:BV (Average)

8 Years
5 Years
3 Years

1.38
1.50
1.50

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.55
8.30
8.30

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var%
Net Sales 503.92 587.21 -14.18% 520.39 523.48 -0.59% 545.30 541.41 0.72% 563.18 565.01 -0.32%
Expenses 453.84 491.42 -7.65% 475.91 480.44 -0.94% 481.20 509.74 -5.60% 490.32 508.99 -3.67%
EBITDA 50.08 95.79 -47.72% 44.48 43.04 3.35% 64.10 31.67 102.40% 72.86 56.02 30.06%
EBIDTM 9.94% 16.31% 8.55% 8.22% 11.76% 5.85% 12.94% 9.91%
Other Income 7.52 8.72 -13.76% 8.38 6.64 26.20% 7.11 5.06 40.51% 7.06 5.15 37.09%
Interest 3.41 4.88 -30.12% 4.30 4.70 -8.51% 4.44 3.51 26.50% 3.95 3.38 16.86%
Depreciation 16.42 12.10 35.70% 16.32 11.73 39.13% 15.67 11.32 38.43% 14.44 10.98 31.51%
PBT 37.77 87.53 -56.85% 32.24 33.25 -3.04% 51.10 21.90 133.33% 61.53 46.81 31.45%
Tax 9.58 22.26 -56.96% 9.01 9.10 -0.99% 13.31 6.23 113.64% 15.32 11.92 28.52%
PAT 28.19 65.27 -56.81% 23.23 24.15 -3.81% 37.79 15.67 141.16% 46.21 34.89 32.44%
PATM 5.59% 11.12% 4.46% 4.61% 6.93% 2.89% 8.21% 6.18%
EPS 4.80 11.12 -56.83% 3.96 4.11 -3.65% 6.44 2.67 141.20% 7.87 5.94 32.49%

Description Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var%
Net Sales 503.92 587.21 -14.18% 520.39 523.48 -0.59% 545.30 541.41 0.72% 563.18 565.01 -0.32%
Expenses 454.40 491.91 -7.63% 476.04 480.80 -0.99% 481.10 509.51 -5.58% 490.66 509.22 -3.64%
EBITDA 49.52 95.30 -48.04% 44.35 42.68 3.91% 64.20 31.90 101.25% 72.52 55.79 29.99%
EBIDTM 9.83% 16.23% 8.52% 8.15% 11.77% 5.89% 12.88% 9.87%
Other Income 7.52 8.73 -13.86% 8.38 6.65 26.02% 7.11 5.07 40.24% 7.06 5.16 36.82%
Interest 3.41 4.88 -30.12% 4.30 4.70 -8.51% 4.44 3.51 26.50% 3.95 3.38 16.86%
Depreciation 16.43 12.11 35.67% 16.34 11.75 39.06% 15.69 11.32 38.60% 14.45 10.98 31.60%
PBT 37.20 87.04 -57.26% 32.09 32.88 -2.40% 51.18 22.14 131.17% 61.18 46.59 31.32%
Tax 9.58 22.26 -56.96% 9.01 9.10 -0.99% 13.31 6.23 113.64% 15.32 11.92 28.52%
PAT 27.62 64.78 -57.36% 23.08 23.78 -2.94% 37.87 15.91 138.03% 45.86 34.67 32.28%
PATM 5.48% 11.03% 4.44% 4.54% 6.94% 2.94% 8.14% 6.14%
EPS 4.70 11.03 -57.39% 3.93 4.05 -2.96% 6.45 2.71 138.01% 7.81 5.91 32.15%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 2,132.79 2,217.11 2,184.02 1,966.98 1,894.47 1,685.33 983.30 710.65 580.42 384.73 563.50 Net Sales Growth -3.80% 1.52% 11.03% 3.83% 12.41% 71.40% 38.37% 22.44% 50.86% -31.72% Cost Of Goods Sold 1,396.95 1,547.09 1,570.51 1,102.84 1,065.01 1,047.25 695.28 477.40 416.20 279.34 369.54 Gross Profit 735.84 670.02 613.51 864.14 829.46 638.08 288.02 233.25 164.21 105.38 193.97 GP Margin 34.50% 30.22% 28.09% 43.93% 43.78% 37.86% 29.29% 32.82% 28.29% 27.39% 34.42% Total Expenditure 1,901.27 1,990.59 1,927.74 1,375.14 1,320.59 1,275.68 863.77 608.45 529.04 373.46 467.75 Power & Fuel Cost - 131.98 78.18 51.46 65.12 63.94 45.66 37.45 46.57 48.58 45.27 % Of Sales - 5.95% 3.58% 2.62% 3.44% 3.79% 4.64% 5.27% 8.02% 12.63% 8.03% Employee Cost - 168.21 141.30 115.55 97.20 78.43 56.10 43.18 35.13 24.72 27.08 % Of Sales - 7.59% 6.47% 5.87% 5.13% 4.65% 5.71% 6.08% 6.05% 6.43% 4.81% Manufacturing Exp. - 43.07 36.86 28.13 28.37 25.68 22.57 16.77 8.83 4.55 6.46 % Of Sales - 1.94% 1.69% 1.43% 1.50% 1.52% 2.30% 2.36% 1.52% 1.18% 1.15% General & Admin Exp. - 6.52 5.12 4.48 2.86 2.63 1.39 1.19 1.17 1.40 1.67 % Of Sales - 0.29% 0.23% 0.23% 0.15% 0.16% 0.14% 0.17% 0.20% 0.36% 0.30% Selling & Distn. Exp. - 61.85 66.84 50.78 48.45 46.72 33.73 20.81 12.81 6.39 11.27 % Of Sales - 2.79% 3.06% 2.58% 2.56% 2.77% 3.43% 2.93% 2.21% 1.66% 2.00% Miscellaneous Exp. - 31.87 28.93 21.90 13.58 11.03 9.04 11.65 8.33 8.48 11.27 % Of Sales - 1.44% 1.32% 1.11% 0.72% 0.65% 0.92% 1.64% 1.44% 2.20% 1.15% EBITDA 231.52 226.52 256.28 591.84 573.88 409.65 119.53 102.20 51.38 11.27 95.75 EBITDA Margin 10.86% 10.22% 11.73% 30.09% 30.29% 24.31% 12.16% 14.38% 8.85% 2.93% 16.99% Other Income 30.07 25.57 32.04 24.30 16.02 10.37 6.33 1.25 1.23 1.32 1.31 Interest 16.10 16.47 8.29 5.83 20.93 51.42 64.35 67.68 61.47 59.11 60.34 Depreciation 62.85 46.13 43.26 38.92 35.73 32.45 30.21 29.84 29.69 28.91 31.63 PBT 182.64 189.49 236.77 571.39 533.24 336.15 31.30 5.93 -38.55 -75.44 5.08 Tax 47.22 49.51 57.18 126.83 171.95 99.45 3.60 1.26 1.48 -8.79 1.78 Tax Rate 25.85% 26.13% 25.66% 22.20% 32.25% 29.59% 11.50% 21.25% -3.84% 11.65% 35.04% PAT 135.42 139.98 165.66 444.56 361.29 236.70 27.70 4.67 -40.03 -66.65 3.30 PAT before Minority Interest 135.42 139.98 165.66 444.56 361.29 236.70 27.70 4.67 -40.03 -66.65 3.30 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.35% 6.31% 7.59% 22.60% 19.07% 14.04% 2.82% 0.66% -6.90% -17.32% 0.59% PAT Growth -3.26% -15.50% -62.74% 23.05% 52.64% 754.51% 493.15% - - - EPS 23.07 23.85 28.22 75.73 61.55 40.32 4.72 0.80 -6.82 -11.35 0.56

Description TTM Mar 23 Mar 22
Net Sales 2,132.79 2,217.11 2,184.02 Net Sales Growth -3.80% 1.52% Cost Of Goods Sold 1,396.95 1,547.09 1,570.51 Gross Profit 735.84 670.02 613.51 GP Margin 34.50% 30.22% 28.09% Total Expenditure 1,902.20 1,991.44 1,925.73 Power & Fuel Cost - 131.98 78.18 % Of Sales - 5.95% 3.58% Employee Cost - 168.21 141.30 % Of Sales - 7.59% 6.47% Manufacturing Exp. - 43.07 36.86 % Of Sales - 1.94% 1.69% General & Admin Exp. - 6.54 5.12 % Of Sales - 0.29% 0.23% Selling & Distn. Exp. - 61.85 66.84 % Of Sales - 2.79% 3.06% Miscellaneous Exp. - 32.70 26.92 % Of Sales - 1.47% 1.23% EBITDA 230.59 225.67 258.29 EBITDA Margin 10.81% 10.18% 11.83% Other Income 30.07 25.61 32.04 Interest 16.10 16.47 8.29 Depreciation 62.91 46.16 43.26 PBT 181.65 188.65 238.78 Tax 47.22 49.51 57.18 Tax Rate 26.00% 26.24% 25.43% PAT 134.43 139.14 167.67 PAT before Minority Interest 134.43 139.14 167.67 Minority Interest 0.00 0.00 0.00 PAT Margin 6.30% 6.28% 7.68% PAT Growth -3.39% -17.02% EPS 22.90 23.70 28.56

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 1,506.55 1,390.27 1,260.43 813.54 474.34 215.74 188.70 185.13 207.20 209.25 Share Capital 58.71 58.71 58.71 56.89 56.89 56.21 56.21 56.21 47.66 48.83 Total Reserves 1,447.84 1,331.56 1,201.72 747.33 408.13 159.53 132.49 128.92 153.56 160.42 Non-Current Liabilities 58.15 56.62 59.11 79.73 210.65 280.29 294.23 304.43 285.87 255.48 Secured Loans 0.00 0.00 0.00 0.00 189.88 236.16 262.37 283.25 253.84 163.91 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 21.96 22.61 18.62 23.26 56.50 Long Term Provisions 1.65 3.01 3.68 3.85 4.59 2.04 1.50 1.18 0.30 0.30 Current Liabilities 502.17 575.29 432.80 453.63 324.79 350.97 327.67 282.92 208.54 276.82 Trade Payables 314.22 409.29 238.83 180.38 120.27 157.61 149.84 115.68 70.25 120.36 Other Current Liabilities 53.93 54.02 41.00 34.46 63.88 50.97 35.84 30.03 17.81 58.57 Short Term Borrowings 79.63 42.75 0.00 55.92 67.72 135.27 140.77 137.09 120.44 96.96 Short Term Provisions 54.39 69.23 152.97 182.87 72.92 7.12 1.22 0.13 0.04 0.94 Total Liabilities 2,066.87 2,022.18 1,752.34 1,346.90 1,009.78 847.00 810.60 772.48 701.61 741.55 Net Block 751.31 560.64 512.36 469.04 411.72 405.64 373.88 399.50 402.82 410.60 Gross Block 994.71 761.99 677.69 595.78 503.91 465.53 403.77 619.96 594.29 569.47 Accumulated Depreciation 243.40 201.35 165.33 126.74 92.19 59.89 29.89 220.47 191.47 158.86 Non Current Assets 1,101.54 881.58 600.19 498.99 457.60 416.02 395.94 415.63 418.12 460.38 Capital Work in Progress 89.64 105.20 48.27 19.19 27.02 6.95 21.26 4.31 4.21 33.06 Non Current Investment 17.71 0.10 0.00 0.00 0.00 0.00 0.05 0.04 0.04 0.00 Long Term Loans & Adv. 9.52 10.77 17.61 1.33 11.56 1.26 0.38 9.01 10.75 13.08 Other Non Current Assets 233.36 204.87 21.95 9.43 7.30 2.17 0.37 2.77 0.30 3.63 Current Assets 965.33 1,140.60 1,152.15 847.91 552.18 430.98 414.66 356.86 283.49 281.17 Current Investments 2.56 2.37 1.22 0.05 0.06 0.06 0.05 0.05 0.01 0.00 Inventories 325.52 409.89 295.15 187.52 188.86 207.45 262.63 227.94 213.42 192.23 Sundry Debtors 505.28 469.80 300.31 272.42 199.16 146.14 112.77 87.26 32.67 49.26 Cash & Bank 20.90 137.88 364.74 154.65 29.60 17.32 16.81 11.94 12.70 11.45 Other Current Assets 111.07 30.99 38.52 24.40 134.50 60.01 22.40 29.67 24.68 28.25 Short Term Loans & Adv. 81.24 89.67 152.21 208.87 126.88 56.79 18.79 26.78 22.19 25.37 Net Current Assets 463.16 565.31 719.35 394.28 227.39 80.01 86.99 73.93 74.95 4.35 Total Assets 2,066.87 2,022.18 1,752.34 1,346.90 1,009.78 847.00 810.60 772.49 701.61 741.55

Description Mar 23 Mar 22
Shareholder's Funds 1,507.72 1,392.28 Share Capital 58.71 58.71 Total Reserves 1,449.01 1,333.57 Non-Current Liabilities 58.15 56.62 Secured Loans 0.00 0.00 Unsecured Loans 0.00 0.00 Long Term Provisions 1.65 3.01 Current Liabilities 502.52 575.29 Trade Payables 314.22 409.29 Other Current Liabilities 54.28 54.02 Short Term Borrowings 79.63 42.75 Short Term Provisions 54.39 69.23 Total Liabilities 2,068.39 2,024.19 Net Block 751.81 560.64 Gross Block 995.24 761.99 Accumulated Depreciation 243.43 201.35 Non Current Assets 1,101.74 881.48 Capital Work in Progress 89.64 105.20 Non Current Investment 17.41 0.00 Long Term Loans & Adv. 9.52 10.77 Other Non Current Assets 233.36 204.87 Current Assets 966.65 1,142.71 Current Investments 2.56 2.37 Inventories 325.52 409.89 Sundry Debtors 505.28 469.80 Cash & Bank 21.83 139.99 Other Current Assets 111.46 30.99 Short Term Loans & Adv. 81.60 89.67 Net Current Assets 464.13 567.42 Total Assets 2,068.39 2,024.19

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 123.14 91.04 379.78 470.80 273.17 119.72 83.34 17.70 -46.96 78.40 PBT 189.49 222.84 571.39 533.24 336.15 31.30 5.93 -38.55 -75.44 5.08 Adjustment 44.42 33.12 27.15 51.93 82.35 91.64 95.92 83.92 81.73 86.38 Changes in Working Capital -63.67 -102.34 -76.51 2.78 -77.64 3.14 -17.45 -27.67 -52.83 -12.31 Cash after chg. in Working capital 170.24 153.62 522.03 587.95 340.86 126.08 84.40 17.70 -46.54 79.15 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -47.10 -62.58 -142.25 -117.15 -67.69 -6.36 -1.06 0.00 -0.42 -0.75 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -119.19 -120.62 -317.25 -184.23 -63.04 -50.38 -22.78 -27.37 -4.79 -12.12 Net Fixed Assets -217.16 -141.23 -110.99 -84.04 -58.45 -47.45 199.24 -25.77 4.03 -13.18 Net Investments -17.80 -1.25 -1.17 0.01 0.00 0.04 -0.01 -0.04 -0.05 0.00 Others 115.77 21.86 -205.09 -100.20 -4.59 -2.97 -222.01 -1.56 -8.77 1.06 Cash from Financing Activity -4.11 -1.64 -58.28 -271.89 -197.46 -70.36 -59.78 9.27 49.69 -65.68 Net Cash Inflow / Outflow -0.16 -31.22 4.25 14.68 12.67 -1.02 0.78 -0.40 -2.07 0.60 Opening Cash & Equivalents 1.12 32.34 28.09 13.41 0.74 1.76 0.98 1.38 15.06 14.46 Closing Cash & Equivalent 0.96 1.12 32.34 28.09 13.41 0.74 1.76 0.98 12.99 15.06

Description Mar 23 Mar 22
Cash From Operating Activity 122.27 93.05 PBT 188.65 224.85 Adjustment 44.41 33.12 Changes in Working Capital -63.69 -102.34 Cash after chg. in Working capital 169.37 155.63 Interest Paid 0.00 0.00 Tax Paid -47.10 -62.58 Other Direct Exp. Paid 0.00 0.00 Extra & Other Items 0.00 0.00 Cash From Investing Activity -120.00 -120.52 Net Fixed Assets -217.16 Net Investments -17.80 Others 114.96 Cash from Financing Activity -4.11 -1.64 Net Cash Inflow / Outflow -1.84 -29.11 Opening Cash & Equivalents 3.23 32.34 Closing Cash & Equivalent 1.39 3.23

Financial Ratios

Standalone /

Consolidated

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 256.61 236.80 214.69 141.36 81.74 38.38 33.57 32.94 42.22 65.67 ROA 6.85% 8.78% 28.69% 30.66% 25.50% 3.34% 0.59% -5.43% -9.24% 0.45% ROE 9.66% 12.50% 43.06% 56.93% 69.54% 13.70% 2.50% -20.72% -34.14% 1.85% ROCE 13.64% 17.16% 54.20% 68.09% 55.53% 15.03% 11.57% 3.68% -2.78% 11.48% Fixed Asset Turnover 2.52 3.03 3.09 3.45 3.48 2.30 1.51 1.06 0.73 1.11 Receivable days 80.26 64.35 53.14 45.43 37.39 47.21 47.21 33.98 35.12 24.85 Inventory Days 60.53 58.91 44.78 36.26 42.92 85.71 115.79 125.04 173.90 103.91 Payable days 85.35 75.31 69.37 41.74 37.73 62.92 46.31 3.40 9.79 8.96 Cash Conversion Cycle 55.45 47.95 28.55 39.95 42.57 69.99 116.69 155.61 199.24 119.80 Total Debt/Equity 0.05 0.03 0.00 0.07 0.61 1.96 2.37 2.44 1.99 1.71 Interest Cover 12.51 27.88 99.01 26.48 7.54 1.49 1.09 0.37 -0.28 1.08

Description Mar 23 Mar 22
Book Value (Rs.) 256.81 237.15 ROA 6.80% 8.28% ROE 9.60% 12.04% ROCE 13.57% 16.25% Fixed Asset Turnover 2.52 2.87 Receivable days 80.26 78.51 Inventory Days 60.53 68.50 Payable days 85.35 95.12 Cash Conversion Cycle 55.45 51.89 Total Debt/Equity 0.05 0.03 Interest Cover 12.45 28.12

Top Investors:

vasudeva commercials limited

enorg limited

g consultants and fabricators pvt ltd

Annual Reports:

News Update:

IOL Chemicals gets certificate of suitability from EDQM for Valsartan
24th Jul 2024, 11:00 AM

This certification will enable the Company to export this product in European and other CEP accepting countries
Read More
IOL Chemicals gets nod to export ‘Fenofibrate API’ in China market
2nd Jul 2024, 10:49 AM

Fenofibrate is used to treat high cholesterol and triglyceride levels in the blood
Read More
IOL Chemicals gets certificate of suitability for ‘Pantoprazole Sodium Sesquihydrate’
12th Jun 2024, 11:41 AM

This certification will enable the Company to export this product in European and other CEP accepting countries
Read More
IOL Chemicals gets CEP certificate for Allopurinol from EDQM
12th Jun 2024, 10:59 AM

This certification will enable the Company to export this product in European and other CEP accepting countries
Read More
IOL Chem & Pharma - Quarterly Results
14th May 2024, 16:59 PM

Read More

IOL Chemicals And Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

BSE: 524164 | NSE: IOLCP

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

IOL Chemicals And Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

BSE: 524164 | NSE: IOLCP

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: